News
Guardiola has cut a tortured, agonised figure for most of a campaign in which the form of his City side fell off a cliff after claiming a historic four successive Premier League titles.
The ADS8910B is a high-speed, high-precision, 18-bit successive approximation register (SAR) analog-to-digital converter (ADC) equipped with an integrated reference buffer and low-dropout (LDO) ...
The circuit primarily consists of an incremental delta-sigma ADC and the proposed 9-bit successive approximation register (SAR) ADC for extended counting. Fabricated in a standard $0.25~\mu $ m CMOS ...
Adcentrx to present new preclinical data at AACR 2025 on the company’s novel ADRX-0405 STEAP1 & ADRX-0134 NaPi2b ADCs. The company will deliver an oral presentation on ADRX-0405, its clinical-stage ...
ABSTRACT: This study introduces a Hybrid Bimodal Model for Analog-to-Digital (ADC) and Digital-to-Analog (DAC) signal conversions, addressing limitations of traditional systems, such as inefficiencies ...
ABSTRACT: This study introduces a Hybrid Bimodal Model for Analog-to-Digital (ADC) and Digital-to-Analog (DAC) signal conversions, addressing limitations of traditional systems, such as inefficiencies ...
The biotech had been developing the Claudin 18.2 ADC, dubbed EO-3021, as a potential treatment for advanced, unresectable or metastatic gastric and gastroesophageal junction cancers. But data from ...
Part 1 covered the fundamental frequency-response measurement method and how to use it to measure the analog input bandwidth for an ADC. Part 2 discusses the DAC’s analog output and offers tips to ...
A 2.1 GS/s 2-Channel Pipeline-SAR ADC With Speed-Enhanced Bootstrap Switch and Low-Latency SAR Logic
Abstract: This paper introduces a 12-bit 2-channel interleaved Pipelined Successive Approximation Register (Pipelined-SAR) Analog-to-Digital Converter (ADC) capable of operating at 2.1 GS/s. A ...
A small Swiss drug developer is being scooped up for its pipeline of three antibody-drug conjugates that offer a next-generation approach to the area of … ...
The deal includes an additional $740 million upon the completion of certain milestones. Araris’ focus is on developing improved antibody-drug conjugates (ADCs) for cancer applications. The company ...
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s technology in two candidates. The Czech biotech disclosed the update on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results